Sefton Technologies Limited

The project aims to tackle the growing problem of bacterial contamination on medical devices used in hospitals without the use of antimicrobial agents, which contribute to the rise in antimicrobial resistance. The project is led by an innovative SME utilising relevant expertise from a leading UK university and specialist suppliers.

The project is a collaboration between a global market leader, two innovative UK SMEs and a leading University to develop an advanced manufacturing process to produce a medical device with antimicrobial properties in order to address the challenge of Hospital Acquired Infections, which cost the NHS £2bn per annum. The project uses the 'Design for Excellen...

This project is a collaboration between Boots (a leading Pharmacy, Health and Well Being company), the University of Liverpool (a member of the Russell Group of Universities) and an innovative SME. The project aims to develop a smart release technology to deliver ingredients on demand within a cosmetic delivery system for a healthcare application. The Uni...

Hospital Acquired Infections (HAIs) cost the NHS £2bn per annum and are a leading cause of death. The project aims to develop methods to impart antimicrobial properties to an important class of materials, which come in contact with patients and via which pathogen transmission occurs most frequently. The consortium aims to do this by utilising the expertis...

Hospital Acquired Infections (HAIs) cost the NHS £2bn per annum and are a leading cause of death. The project aims to develop methods to impart antimicrobial properties to an important class of materials, which come in contact with patients and via which pathogen transmission occurs most frequently. The SME aims to do this by utilising the expertise of a ...